Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
320-340
Author(s):
Pepita Gimenez-Bonafe, Avelina Tortosa and Ricardo Perez-Tomas
The Applicability of mTOR Inhibition in Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
439-450
Author(s):
I.R. H.M. Konings, J. Verweij, E. A.C. Wiemer and S. Sleijfer
Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
105-110
Author(s):
Mathilde Lechevrel and Brigitte Sola
Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Journal:
Current Molecular Medicine
Volume:
9
Page:
425-434
Author(s):
Yuri Kim, Qun Lin, Peter M. Glazer and Zhong Yun
The Return of the INGs, Histone Mark Sensors and Phospholipid Signaling Effectors
Journal:
Current Drug Targets
Volume:
10
Page:
418-431
Author(s):
Dennis J. Bua and Olivier Binda
ING Proteins as Potential Anticancer Drug Targets
Journal:
Current Drug Targets
Volume:
10
Page:
442-454
Author(s):
M. Unoki, K. Kumamoto and C. c. Harris
Potential Usage of ING Family Members in Cancer Diagnostics and Molecular Therapy
Journal:
Current Drug Targets
Volume:
10
Page:
465-476
Author(s):
Mehmet Gunduz, Kadir Demircan, Esra Gunduz, Naoki Katase, Ryo Tamamura and Hitoshi Nagatsuka
Biocompatibility and Solubility of Fe3O4-BSA Conjugates with Human Blood
Journal:
Current Nanoscience
Volume:
5
Page:
177-181
Author(s):
D. Stamopoulos, V. Gogola, E. Manios, E. Gourni, D. Benaki, D. Niarchos and M. Pissas
The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
Journal:
Current Signal Transduction Therapy
Volume:
4
Page:
122-129
Author(s):
Brendan Meyer, Wai M. Liu, Angus G. Dalgleish and Christine Galustian
Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
4
Page:
110-121
Author(s):
Lauren R. Mitchell, Jeffrey M. Albert and Bo Lu